Comparative Effectiveness of CRT-D Versus Defibrillator Alone in HF Patients with Moderate-to-Severe Chronic Kidney Disease

Journal of the American College of Cardiology

Volumn 66, Issue 23, 2015, Pages 2618-2629

  Friedman, Daniel J ^a   Singh, Jagmeet P ^b   Curtis, Jeptha P ^c   Tang, W H Wilson ^d   Bao, Haikun ^c   Spatz, Erica S ^c   Hernandez, Adrian F ^a,e   Patel, Uptal D ^a,e   Al Khatib, Sana M ^a,e  

^a DUKE UNIVERSITY HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

biventricular; cardiomyopathy; chronic kidney disease; pacemaker

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TICLOPIDINE; WARFARIN;

AGED; ARTICLE; ATRIAL FIBRILLATION; CARDIAC RESYNCHRONIZATION THERAPY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CURRENT PROCEDURAL TERMINOLOGY; DISEASE COURSE; DISEASE REGISTRY; DISEASE SEVERITY; ETHNICITY; FEMALE; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HEART FAILURE; HEART TAMPONADE; HEART VENTRICLE CONDUCTION; HOSPITALIZATION; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LONGEVITY; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORBIDITY; MORTALITY; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PRIORITY JOURNAL; PROBABILITY; QRS INTERVAL; QUALITY OF LIFE; SYSTOLIC BLOOD PRESSURE; CARDIOVERSION; COMORBIDITY; COMPARATIVE EFFECTIVENESS; COMPARATIVE STUDY; DEVICES; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RENAL INSUFFICIENCY, CHRONIC; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARDIAC RESYNCHRONIZATION THERAPY; COMORBIDITY; COMPARATIVE EFFECTIVENESS RESEARCH; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MEDICARE; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY, CHRONIC; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 84961614008     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.09.097     Document Type: Article

References (26)

1. W.M. McClellan, R.D. Langston, and R. Presley Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease J Am Soc Nephrol 15 2004 1912 1919
2. P.A. Heidenreich, N.M. Albert, L.A. Allen, and et al. Forecasting the impact of heart failure in the united states: a policy statement from the American Heart Association Circ Heart Fail 6 2013 606 619
3. W.T. Abraham, W.G. Fisher, A.L. Smith, and et al. Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853
4. J.G. Cleland, J.C. Daubert, E. Erdmann, and et al. Cardiac Resynchronization-Heart Failure Study I. The effect of cardiac resynchronization on morbidity and mortality in heart failure N Engl J Med 352 2005 1539 1549
5. A.J. Moss, W.J. Hall, D.S. Cannom, and et al. Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 2009 1329 1338
6. A.S. Tang, G.A. Wells, M. Talajic, and et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure N Engl J Med 363 2010 2385 2395
7. L.A. Cannizzaro, J.P. Piccini, U.D. Patel, and A.F. Hernandez Device therapy in heart failure patients with chronic kidney disease J Am Coll Cardiol 58 2011 889 896
8. E.C. Adelstein, A. Shalaby, and S. Saba Response to cardiac resynchronization therapy in patients with heart failure and renal insufficiency Pacing Clin Electrophysiol 33 2010 850 859
9. D.J. Friedman, G.A. Upadhyay, G. Singal, and et al. Usefulness and consequences of cardiac resynchronization therapy in dialysis-dependent patients with heart failure Am J Cardiol 112 2013 1625 1631
10. N. Garg, G. Thomas, G. Jackson, and et al. Cardiac resynchronization therapy in CKD: a systematic review Clin J Am Soc Nephrol 8 2013 1293 1303
11. K. Damman, W.H. Tang, G.M. Felker, and et al. Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data J Am Coll Cardiol 63 2014 853 871
12. J.P. Piccini, A.F. Hernandez, D. Dai, and et al. Use of cardiac resynchronization therapy in patients hospitalized with heart failure Circulation 118 2008 926 933
13. S.C. Hammill, M.S. Kremers, L.W. Stevenson, and et al. Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure Heart Rhythm 7 2010 1340 1345
14. M.S. Kremers, S.C. Hammill, C.I. Berul, and et al. The national ICD registry report: version 2.1 including leads and pediatrics for years 2010 and 2011 Heart Rhythm 10 2013 e59 e65
15. J.C. Messenger, K.K. Ho, C.H. Young, and et al. The National Cardiovascular Data Registry (NCDR) data quality brief: the NCDR data quality program in 2012 J Am Coll Cardiol 60 2012 1484 1488
16. B.G. Hammill, A.F. Hernandez, E.D. Peterson, and et al. Modification of Diet in Renal Disease Study Group. Linking inpatient clinical registry data to Medicare claims data using indirect identifiers Am Heart J 157 2009 995 1000
17. A.S. Levey, J.P. Bosch, J.B. Lewis, and et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Ann Intern Med 130 1999 461 470
18. V. Prasad, and A.B. Jena Prespecified falsification end points: can they validate true observational associations? JAMA 309 2013 241 242
19. J. Mathew, R. Katz, M. St John Sutton, and et al. Chronic kidney disease and cardiac remodelling in patients with mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study Eur J Heart Fail 14 2012 1420 1428
20. D.J. Friedman, G.A. Upadhyay, G. Singal, and et al. Usefulness and consequences of cardiac resynchronization therapy in dialysis-dependent patients with heart failure Am J Cardiol 112 2013 1625 1631
21. G. Boerrigter, L.C. Costello-Boerrigter, W.T. Abraham, and et al. Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate J Card Fail 14 2008 539 546
22. G. Lin, B.J. Gersh, E.L. Greene, and et al. Renal function and mortality following cardiac resynchronization therapy Eur Heart J 32 2011 184 190
23. M.S. Buiten, M.K. De Bie, A.C. Van Der Heijden, and et al. Chronic kidney disease and implantable cardioverter defibrillator related complications: 16 years of experience J Cardiovasc Electrophysiol 25 2014 998 1004
24. J.M. Prutkin, M.R. Reynolds, H. Bao, and et al. Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry Circulation 130 2014 1037 1043
25. O. Opelami, A. Sakhuja, X. Liu, and et al. Outcomes of infected cardiovascular implantable devices in dialysis patients Am J Nephrol 40 2014 280 287
26. C.M. Tracy, A.E. Epstein, D. Darbar, and et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 61 2013 e6 e75